Bml Capital Management, LLC Pmv Pharmaceuticals, Inc. Transaction History
Bml Capital Management, LLC
- $132 Billion
- Q2 2025
A detailed history of Bml Capital Management, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 5,000,000 shares of PMVP stock, worth $7.1 Million. This represents 4.01% of its overall portfolio holdings.
Number of Shares
5,000,000
Previous 3,747,612
33.42%
Holding current value
$7.1 Million
Previous $4.08 Billion
29.75%
% of portfolio
4.01%
Previous 3.31%
Shares
6 transactions
Others Institutions Holding PMVP
# of Institutions
62Shares Held
37.6MCall Options Held
100Put Options Held
0-
Orbimed Advisors LLC San Diego, CA6.48MShares$9.19 Million0.25% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$5.3 Million1.89% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.19MShares$4.53 Million0.07% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.73 Million0.92% of portfolio
-
Alkeon Capital Management LLC New York, NY2.34MShares$3.33 Million0.0% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $64.8M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...